Publications

What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes?

Oct 2018

Comparing neurodevelopmental outcomes at 30 months by presence of hydrocephalus and shunt status among children enrolled in the MOMS trial

2018

Impact of lifestyle behavior change on glycemic control in youth with type 2 diabetes

Feb 2018

Sex hormones and measures of kidney function in the Diabetes Prevention Program Outcomes Study

5-Nov 2018

Association between gestational weight gain and perinatal outcomes

2018

How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA‐REG OUTCOME trial

Feb 2018

Properties of composite time to first event versus joint marginal analyses of multiple outcomes

Nov 30, 2018

Child Neurodevelopmental Outcomes by Prepregnancy Body Mass Index and Gestational Weight Gain

2018

Genetic variation, magnesium sulfate exposure, and adverse neurodevelopmental outcomes following preterm birth

2018

Burden of Urological Complications in Men and Women With Long-standing Type 1 Diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Cohort

Oct 2018

Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease

Oct 9, 2018

Insulin Sensitivity and Diabetic Kidney Disease in Children and Adolescents With Type 2 Diabetes: An Observational Analysis of Data From the TODAY Clinical Trial

Jan 2018